Article Versions Notes

Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, et al. A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma. Diagnostics. 2022; 12(2):539. https://doi.org/10.3390/diagnostics12020539

Gourari, Karim, Julien Catherine, Soizic Garaud, Joseph Kerger, Antonia Lepida, Aspasia Georgala, Fabienne Lebrun, Maria Gomez Galdon, Thierry Gil, Karen Willard-Gallo, and et al. 2022. "A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma" Diagnostics 12, no. 2: 539. https://doi.org/10.3390/diagnostics12020539

Gourari, K., Catherine, J., Garaud, S., Kerger, J., Lepida, A., Georgala, A., Lebrun, F., Gomez Galdon, M., Gil, T., Willard-Gallo, K., & Langouo Fontsa, M. (2022). A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma. Diagnostics, 12(2), 539. https://doi.org/10.3390/diagnostics12020539